The invention provides a formulation comprising a buffer with a pH from about4.0 to about 6.0, proline and an effective amount of a polypeptide. The polypeptidecan be an antibody. The specification also provides methods of preparing theformulation, a kit containing the formulation and methods of using the formulation.